Back to all news
ECR 2026: Radiologists Push for Stronger Evidence and EU Support in Imaging AI
Tags:Policy
European radiologists at ECR 2026 call for more resources to achieve strong evidence and societal impact for radiology AI, especially under new EU HTA regulation.
Key Details
- 1Radiologists highlight the need for national or EU funding to achieve robust evidence for AI applications.
- 2Current studies on radiology AI are predominantly small and retrospective due to resource constraints.
- 3The new EU Health Technology Assessment (HTA) regulation began Jan 12, 2025, aiming to standardize evaluation and reimbursement decisions.
- 4Radiologists are increasingly expected to generate evidence on clinical utility, patient outcomes, cost-effectiveness, and system impact.
- 5Joint Clinical Assessments (JCAs) for medical devices, including radiology AI, will be selected starting June 2026.
- 6Improved collaboration and feedback loops between radiologists, industry, and HTA bodies are deemed essential for valuable AI adoption.
Why It Matters
The shift to HTA-driven evaluation could greatly influence how imaging AI is adopted and reimbursed across the EU, making it vital for radiologists to actively participate in evidence generation and regulatory processes. This development may affect AI deployment, clinical impact, and patient care standards in European radiology.
Source
AuntMinnie
Related News
•HealthExec
EFF Sues CMS For Transparency on AI-Powered Medicare Prior Authorization
EFF has sued CMS to compel disclosure about the WISeR pilot deploying AI for Medicare prior authorization.
•Radiology Business
AI Diagnostic Tools in Imaging Cited as Top Patient Safety Issue for 2026
ECRI ranks AI diagnostic challenges in imaging as the leading patient safety concern for 2026.
•Radiology Business
Harrison.ai Petitions FDA for CAD Device Premarket Review Exemption
Harrison.ai has petitioned the FDA to exempt some radiology AI devices from premarket review, prompting mixed feedback from industry stakeholders.